Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Irene Robinson

  • Home
  • Author: Irene Robinson

Sentiments decline for FAANG, yet Netflix has a silver lining

A slip in net income and revenue driven by lockdowns during the quarter affected most of FAANG’s sentiments, says GlobalData, a leading data and analytics company. According to Globaldata’s Filing Analytics platform, sentiment scores for Facebook, Amazon and Google declined by more than 20% in Q1 2020 (compared to Q4 2019), while Netflix, witnessed only […]
Read more

Fujifilm and Ansun’s efforts to repurpose their influenza therapies to treat COVID-19 draw efficacy skepticism

With Fujifilm Toyama Chemical’s Avigan (favipiravir) already approved in Japan for influenza, that country had announced plans to stockpile two million courses of the oral drug for COVID-19, but reporting by Reynald Castañeda, Pharma Writer for the Investigative News team at GlobalData, a leading data and analytics company, notes that there are reservations about the drug’s potential in treating […]
Read more

Spartan’s COVID-19 test recall illustrates challenges of rapid medical device approval

Following the announcement that Spartan Bioscience has recalled its rapid COVID-19 test due to concerns by Health Canada; Azadeh Laffafian PhD, Medical Device Analyst at GlobalData, a leading data and analytics company, offers her view: “Recall of Spartan’s COVID-19 test is not surprising as extraordinary circumstances have accelerated the approval of medical devices. While fast […]
Read more

Telefónica tie-up with Virgin Media would signal seismic shift in UK multiplay market

Following the news that Telefónica has confirmed the current discussions with Liberty Global regarding a potential integration of their respective UK telecommunications businesses, O2 UK and Virgin Media; Natasha Rybak, Principal Analyst at GlobalData, a leading data and analytics company, offers her view on the potential merger’s impact on the UK multiplay market; “Telefónica’s talks […]
Read more

Stryker’s US orthopedics and spines sales take big hit but will see a turnaround as pandemic recedes

Following the announcement that Stryker’s US orthopedics and spine sales were down approximately 65% in April 2020; Aliyah Farouk, Medical Device Analyst at GlobalData, a leading data and analytics company, offers her view: “With all elective procedures practically halted in the US, it is no surprise that Stryker’s orthopedics and spine sales were drastically affected […]
Read more

Dexcom expected to hold position as CGM market leader after exceeding expectations with Q1 results

Following the announcement that Dexcom’s Q1 2020 revenue increased by 44% year-over-year; Aliyah Farouk, Medical Device Analyst at GlobalData, a leading data and analytics company, offers her view: “GlobalData expects Dexcom to retain its position as the market leader for continuous glucose monitoring (CGM) systems following its strong Q1 results. Dexcom’s surge in revenue was […]
Read more

Pharmaceutical professionals say employee safety and supply chain disruption are top COVID-19 concerns in latest GlobalData survey

Pharmaceutical industry professionals around the world believe that employee safety and supply chain disruption are their businesses’ number one concerns from COVID-19, the latest survey data from GlobalData, a leading data and analytics company, suggests. GlobalData’s latest report, ‘Coronavirus Disease 2019 (COVID-19) Sector Impact: Pharmaceutical Trade and Supply Chain Survey – Q1 2020’, reveals that 21% […]
Read more

Google is getting tough on COVID-19 misinformation

Following the news that Google’s YouTube is bringing fact-checking information panels to the US to curb COVID-19 related misinformation; Laura Petrone, Senior Analyst atGlobalData, a leading data and analytics company, offers her view: “The tech giant is stepping up efforts to protect its video platform against the deluge of COVID-19 misinformation. While Google has so […]
Read more

SeaStar Medical to test immunomodulating device for the treatment of COVID-19 patients

Following the announcement that SeaStar Medical will initiate a pilot study of aselective cytopheretic device (SCD) in COVID-19 patients; Azadeh Laffafian, Medical Device Analyst at GlobalData, a leading data and analytics company, offers her view: “SeaStar’s SCD targets proinflammatory neutrophils and monocytes during continuous renal replacement therapy (CRRT) to combat cytokine storm in severely ill […]
Read more

Next lowers outlook but is still in a better position than many rivals

Following today’s release of Next Q1 figures for 2020/21, Sofie Willmott, Lead Retail Analyst at GlobalData, a leading data and analytics company, comments: ‘‘Since it initially updated on its full year outlook in mid-March, Next’s worst case scenario has gone from bad to much worse with full-price sales now expected to fall up to 40% (versus its […]
Read more

Roche’s Actemra a possible candidate for severe COVID-19 treatment

Roche’s Actemra (tocilizumab) generated $687m in the first quarter of 2020, a 30% increase compared to the same period in 2019, due to evidence of effective treatment in severe COVID-19 patients experiencing respiratory failure. However, Actemra’s Q1 sales increase may be a one-off occurrence as Kevzara fell short in its Phase II trial, says GlobalData, […]
Read more
,

NHS collaborates with leading technology providers to develop COVID-19 response data platform

The National Health Service’s (NHS) data platform will help the country implement a co-ordinated and effective response to the rapidly evolving COVID-19 crisis in the UK, says GlobalData, a leading data and analytics company. Kathryn Whitney, MSc, GlobalData Director of Thematic Analysis, comments: “This data platform will give key decision makers in the NHS real-time […]
Read more
1 … 12 13 14 15